Comparing inhaled versus intravenous tranexamic acid for coughing up blood
Treatments studied
Part of Lungs & breathing clinical trials.
This study compares two ways of giving tranexamic acid, a medicine that helps blood clot, to stop bleeding in the lungs. One way is through a breathing mist (inhaled), and the other is through a vein (IV). The goal is to see which method works better and is safer for people who are coughing up blood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You must be coughing up blood (hemoptysis) right now.
- You must be willing to sign a form agreeing to participate.
- You cannot be allergic to tranexamic acid.
- You cannot have had a blood clot (like in your legs, lungs, or brain) before, or have any active clotting problems.
- You cannot have severe kidney disease, recent bleeding in your bladder/kidneys, a recent stent or graft, or bleeding in the brain.
- You cannot be pregnant or breastfeeding, and you must not need immediate surgery or a breathing tube.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two ways to give a medicine called tranexamic acid (which helps blood clot) to people who are coughing up blood. One way is through a nebulizer (breathing in a mist), and the other is through an IV (into a vein). The goal is to see which method works better to stop the bleeding.
This study tests a procedure to stop bleeding in the lungs. It may help people who are coughing up blood that hasn't stopped with other treatments.
This Phase 3 study tests whether inhaled tranexamic acid can reduce lung bleeding (pulmonary hemorrhage) in people with cancer who are on a breathing machine. If you qualify, you may receive the study drug to help stop bleeding in the lungs.
This trial tests two medicines—ACT (a blood thinner) and tranexamic acid (a medicine to reduce bleeding)—to see which is better at controlling bleeding during heart surgery. It is for adults having planned heart surgery with a heart-lung machine.
This study compares different doses of tranexamic acid, a medicine that reduces bleeding, in patients having planned heart surgery with a heart-lung machine. It aims to find the best dose to prevent blood loss.
This study compares two ways of giving a medicine called tranexamic acid — as a pill or through an IV — to see which works better at reducing bleeding during heart bypass surgery. If you are having heart surgery without a heart-lung machine, this trial may help you recover with less bleeding.
Hear when a new Hemoptysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.